1. Home
  2. NSYS vs KPTI Comparison

NSYS vs KPTI Comparison

Compare NSYS & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$12.46

Market Cap

40.1M

Sector

Technology

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$2.01

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
KPTI
Founded
1981
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.1M
47.6M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
NSYS
KPTI
Price
$12.46
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.00
AVG Volume (30 Days)
14.6K
2.3M
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
80.85
N/A
EPS
0.09
N/A
Revenue
$14,371,000.00
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.36
P/E Ratio
$141.67
N/A
Revenue Growth
7.01
0.57
52 Week Low
$6.50
$1.80
52 Week High
$18.01
$10.99

Technical Indicators

Market Signals
Indicator
NSYS
KPTI
Relative Strength Index (RSI) 38.56 18.61
Support Level $11.94 N/A
Resistance Level $15.35 $7.46
Average True Range (ATR) 1.06 0.30
MACD -0.10 -0.10
Stochastic Oscillator 7.98 3.53

Price Performance

Historical Comparison
NSYS
KPTI

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: